Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

Suggested remit: To appraise the clinical and cost effectiveness of serplulimab with carboplatin and etoposide within its marketing authorisation for untreated extensive-stage small-cell lung cancer.

Patients with brain metastases achieved a median OS of 16.3 months compared to those on the active comparator with OS of 8.7 ...

Dr. Debu Tripathy, editor-in-chief of CURE magazine, discusses the advancements made in small cell lung cancer.

Historically, ABVD (doxorubicin hydrochloride [Adriamycin], bleomycin, vinblastine sulfate, and dacarbazine) chemotherapy and ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...

This case demonstrates the pivotal role of a cohesive multidisciplinary team in navigating the complex care of oncology ...

With pivotal trial results and an approval from the FDA, the landscape is changing for patients with small cell lung cancer.

Transaction Will Maximize the Access and Uptake of COSELA® (trilaciclib), the First and Only Proactive Multilineage Myeloprotection Agent -- G1 ...

淋巴瘤是一种起源于造血系统的恶性肿瘤，除了毛发、指甲、牙齿这些没有淋巴结或淋巴组织的地方，淋巴瘤可以发生在全身不同的各个部位。该病初起时症状很隐匿，常被形容为“最会伪装的疾病”。